Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2026-05-12 Major Shareholding Noti…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Major shareholder disclosure in Medistim ASA - Attachment: 2026-05-12_Medistim_major_shareholder_disclosure.pdf
Major Shareholding Notification Classification · 95% confidence The document is an ESMA ‘Standard form for notification of major holdings’ where SEB Funds AB reports its voting rights crossing a threshold on Medistim ASA shares. It is clearly a notification of changes in significant share ownership levels as required by the Major Shareholding Notification rules (Directive 2004/109/EC). There is no financial performance data, management commentary, or proxy solicitation—this is purely a threshold disclosure. Therefore, it should be classified as Major Shareholding Notification (MRQ).
2026-05-12 English
Major shareholder disclosure in Medistim ASA
Major Shareholding Notification Classification · 92% confidence The document title and text clearly indicate a major shareholder disclosure, i.e., notification of changes in significant share ownership levels. This matches the definition of a Major Shareholding Notification (Code: MRQ).
2026-05-12 English
Ex dividend NOK 8.00 today
Notice of Dividend Amount Classification · 100% confidence The document announces the ex-dividend date and amount (NOK 8.00) for Medistim ASA shares, indicating a dividend-related announcement. It is a brief notice about dividend details, not a full dividend report or financial statement. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2026-05-07 Norwegian
First quarter financial results 2026 for Medistim ASA - Attachment: Q1 2026 PPT presentation FINAL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'First Quarter 2026 Financial Results' and contains detailed financial statements including profit & loss, balance sheet, cash flow, and segment updates for Q1 2026. It includes quarterly financial data, analysis of sales by region and product, and management commentary on business segments and strategy implementation. The presence of comprehensive financial data for a quarter, including income statement, balance sheet, and cash flow, indicates this is a quarterly financial report. The document is about 15,000 characters long, which is substantial and contains actual financial data, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2026-05-07 Norwegian
First quarter financial results 2026 for Medistim ASA - Attachment: Q1 2026 Financial Report-FINAL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Q1 2026 Financial Report' and contains detailed financial results for the first quarter of 2026, including sales figures, geographic splits, operating profit, EBIT, balance sheet data, and operational status. It references IFRS and IAS 34 standards for interim financial reporting, which are typical for quarterly reports. The content includes comprehensive financial data and analysis for a period shorter than a full fiscal year, specifically the first quarter. There is no indication that this is merely an announcement or a certification; the document contains substantive financial statements and management commentary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-05-07 Norwegian
First quarter financial results 2026 for Medistim ASA
Interim / Quarterly Report Classification · 95% confidence The document is titled 'First quarter financial results 2026 for Medistim ASA' and contains detailed financial data for the first quarter, including sales figures, operating profit, EBIT margin, geographic sales breakdown, cash position, and dividend decisions. The presence of comprehensive financial results and analysis for a quarter indicates this is a quarterly financial report. The document length is short (1191 characters), but it contains substantive financial data, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2026-05-07 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.